FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

FDA Launches PreCheck Drug Manufacturing Pilot

FDA launches its new PreCheck pilot program aimed at strengthening domestic pharmaceutical manufacturing by providing earlier regulatory engagement an...

Medical Devices

Citizen Petition Seeks Database for Medical Device Labels

A patient safety advocacy group files a citizen petition urging FDA to create a comprehensive public database of medical device labels.

latest-news-card-1
Human Drugs

Floridas FDA-Authorized Canadian Drug Import Program Stalls

Floridas FDA-authorized drug importation program stalls and has yet to deliver any imported medicines more than two years after receiving final agency...

latest-news-card-1
Human Drugs

Aquestives Epinephrine Film Gets Complete Response

FDA sends Aquestive Therapeutics a complete response letter for its NDA for Anaphylm, a sublingual epinephrine film for treating Type I allergic react...

latest-news-card-1
Human Drugs

$17.9 Million Settlement in Generic Drug Price-Fixing Case

New York Attorney General Letitia James and a bipartisan coalition of 47 other attorneys general secure $17.85 million from drug manufacturers Bausch ...

latest-news-card-1
Human Drugs

Complete Response on Pharmings Pediatric sNDA for Joenja

FDA issues Pharming Group a complete response letter for its supplemental NDA seeking expanded approval of Joenja (leniolisib) for children aged 4 to ...

latest-news-card-1
Medical Devices

Warning Letter Sent to Beta Bionics

FDA issues Beta Bionics a Warning Letter following an inspection of the companys Irvine, CA, facility conducted 6/2025.

latest-news-card-1
Human Drugs

FDA Accepts Exelixis NDA for Metastatic Colorectal Cancer

FDA accepts for review an Exelixis NDA for zanzalintinib in combination with the immune checkpoint inhibitor atezolizumab for patients with previously...

latest-news-card-1
Human Drugs

FDA Releases Corrected Rejection Letter for Corcept NDA

FDA releases a corrected version of a 12/30 Complete Response Letter issued to Corcept Therapeutics, indicating that the agency had repeatedly warned ...

latest-news-card-1
Human Drugs

Ultragenyx Resubmits BLA for Gene Therapy

Ultragenyx Pharmaceutical resubmits a BLA seeking accelerated approval for UX111, an AAV9 gene therapy for the treatment of Sanfilippo syndrome Type A...